FIRSTREGULARSESSION
HOUSEBILLNO.929
103RDGENERALASSEMBLY
INTRODUCEDBYREPRESENTATIVESTINNETT.
2251H.01I JOSEPHENGLER,ChiefClerk
ANACT
Torepealsection336.010,RSMo,andtoenactinlieuthereofonenewsectionrelatingtothe
practiceofoptometry.
BeitenactedbytheGeneralAssemblyofthestateofMissouri,asfollows:
SectionA.Section336.010,RSMo,isrepealedandonenewsectionenactedinlieu
2thereof,tobeknownassection336.010,toreadasfollows:
336.010.1.The"practiceofoptometry"istheexamination,diagnosis,[treatment,
2andpreventativecare]prevention,andtreatment,surgicalornonsurgical,oftheeye,
3adnexa,andvision.Thepracticeincludes,butisnotlimitedto:
4 (1)Theexaminationoftheeye,adnexa,andvisiontodeterminetheaccommodative
5andrefractivestates,visualperception,conditions,anddiseases;
6 (2)Thediagnosisandtreatmentofconditionsordiseasesoftheeye,adnexa,and
7vision;
8 (3)Theperformanceofdiagnosticproceduresandorderingoflaboratoryandimaging
9testsforthediagnosisofvisionandconditionsanddiseasesoftheeyeandadnexa;
10 (4)Theprescriptionandadministrationofpharmaceuticalagents[, excluding
11injectableagents,] forthepurposeofexamination,diagnosis,andtreatmentofvisionand
12conditionsordiseasesoftheeyeandadnexa;
13 (5)Theremovalofsuperficialforeignbodiesfromtheeyeoradnexa;
14 (6)Notwithstandingtheprovisionsofanyotherlawtothecontrary,including
15section334.010,thecorrectionandreliefofocularabnormalitiesbysurgicalprocedures
16notexcludedundersubsection2ofthissection;
EXPLANATION—Matterenclosedinbold-facedbrackets[thus] intheabovebillisnotenactedandis
intendedtobeomittedfromthelaw.Matterinbold-facetypeintheabovebillisproposedlanguage. 17 (7)Theemploymentofobjectiveorsubjectivemechanicalmeanstodeterminethe
18accommodativeorrefractivestatesofthehumaneye;
19 [(7)](8)Theprescriptionoradaptationoflenses,prisms,devices,orocularexercises
20tocorrectdefectsorabnormalconditionsofthehumaneyeorvisionortoadjustthehuman
21eyetospecialconditions;
22 [(8)](9)Theprescriptionandfittingofophthalmicorcontactlensesanddevices;
23 [(9)](10)Theprescriptionandadministrationofvisiontherapy;and
24 [(10)] (11)Theprescriptionandadministrationoflowvisioncare.
25 2.Theboardshallcontinuetoreviewsurgicalproceduresnotlistedinthis
26subsectionbutwhichshallbeexcludedfromthescopeofthepracticeofoptometry.The
27followingproceduresarenotwithinthescopeofoptometryandanoptometrist[may]
28shallnotperform[surgery,includingtheuseoflasersfortreatmentofanydiseaseor
29conditionorforthecorrectionofrefractiveerror] suchprocedures,exceptforthe
30preoperativeandpostoperativecareoftheseprocedures:
31 (1)Retinalaserprocedures,laser-assistedinsitukeratomileusis(LASIK),and
32photorefractivekeratectomy(PRK);
33 (2)Nonlasersurgeryrelatedtoremovaloftheeyefromalivinghumanbeing;
34 (3)Nonlasersurgeryrequiringfullthicknessincisionorexcisionofthecorneaor
35scleraotherthanparacentesisinanemergencysituationrequiringimmediatereduction
36ofthepressureinsidetheeye;
37 (4)Penetratingkeratoplasty(cornealtransplant)orlamellarkeratoplasty;
38 (5)Nonlasersurgeryrequiringincisionoftheirisandciliarybody,includingiris
39diathermyorcryotherapy;
40 (6)Nonlasersurgeryrequiringincisionofthevitreous;
41 (7)Nonlasersurgeryrequiringincisionoftheretina;
42 (8)Nonlasersurgicalextractionofthecrystallinelens;
43 (9)Nonlasersurgicalintraocularimplants;
44 (10)Incisionalorexcisionalnonlasersurgeryoftheextraocularmuscles;
45 (11)Nonlasersurgeryoftheeyelidforeyelidmalignanciesorforincisional
46cosmeticormechanicalrepairofblepharochalasis,ptosis,andtarsorrhaphy;
47 (12)Nonlasersurgeryofthebonyorbit,includingorbitalimplants;
48 (13)Incisionalorexcisionalnonlasersurgeryofthelacrimalsystemotherthan
49lacrimalprobingorrelatedprocedures;
50 (14)Nonlasersurgeryrequiringfullthicknessconjunctivoplastywithgraftor
51flap;
52 (15)Anynonlasersurgicalprocedurethatdoesnotprovideforthecorrection
53andreliefofocularabnormalities;
HB929 2 54 (16)Laserornonlaserinjectionintotheposteriorchamberoftheeyetotreat
55anymacularorretinaldisease;and
56 (17)Theadministrationofgeneralanesthesia.
57 3.Asusedinthischapter,exceptasthecontextmayotherwiserequire,thefollowing
58termsmean:
59 (1)"Eye",thehumaneye;
60 (2)"Adnexa",allstructuresadjacenttotheeyeandtheconjunctiva,lids,lashes,and
61lacrimalsystem;
62 (3)"Board",theMissouristateboardofoptometry;
63 (4)"Diagnosticpharmaceuticalagents",topicallyappliedpharmaceuticalsusedfor
64thepurposeofconductinganexaminationoftheeye,adnexa,andvision;
65 (5)"Lowvisioncare",theexamination,treatment,andmanagementofpatientswith
66visualimpairmentsnottreatablebyconventionaleyewearorcontactlensesandmayincludea
67visionrehabilitationprogramtoenhanceremainingvisionskills;
68 (6)"Pharmaceuticalagents",anydiagnosticandtherapeuticdrugorcombinationof
69drugsthatassistthediagnosis,prevention,treatment,ormitigationofabnormalconditionsor
70symptomsofthehumaneye,adnexa,andvision;
71 (7)"Therapeuticpharmaceuticalagents",thosepharmaceuticals[, excluding
72injectableagents,] usedforthetreatmentofconditionsordiseasesoftheeye,adnexa,and
73vision;
74 (8)"Visiontherapy",atreatmentregimenttoimproveapatient'sdiagnosedvisual
75dysfunctions,preventthedevelopmentofvisualproblems,orenhancevisualperformanceto
76meetthedefinedneedsofthepatient.
âś”
HB929 3